Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 8889711 Pyrazolopyridine derivatives as anticancer agent

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Nicolas Rahier0

Patrice Mayer0

Philippe Schambel0

Rémi Rabot0

El Bachir Kaloun0

Hugues Bienayme0

Karim Bedjeguelal0

Arnaud Marchand0

Date of Patent

November 18, 2014

0

Patent Application Number

135007570

Date Filed

October 13, 2010

0

Patent Citations Received

US Patent 12122767 Bicyclic heterocycles as FGFR inhibitors

0

US Patent 11840534 Substituted tricyclic compounds as FGFR inhibitors

0

US Patent 11939331 Tricyclic heterocycles as FGFR inhibitors

0

US Patent 12012409 Bicyclic heterocycles as FGFR inhibitors

0

US Patent 12024517 Salts of an FGFR inhibitor

0

US Patent 12065494 Combination therapy comprising an FGFR inhibitor and a Nectin-4 targeting agent

0

US Patent 12083124 Bicyclic heterocycles as FGFR inhibitors

0

Patent Primary Examiner

Niloofar Rahmani

0

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 8889711 Pyrazolopyridine derivatives as anticancer agent

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool